ReviewFrontiers in behavioral neuroscience2016

DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome.

Arnaud Duchon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.